Ethyl 2-oxocyclopentanecarboxylate → 2-(4-Cyclohexyl-phenoxymethyl)-1,2,7,8-tetrahydro-6H-3-oxa-4,8b-diaza-as-indacen-5-one
반응식
[CH:1]1([C:7]2[CH:20]=[CH:19][C:10]([O:11][CH2:12][C@H:13]3[O:17][C:16]([NH2:18])=[N:15][CH2:14]3)=[CH:9][CH:8]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.C([O:23][C:24]([CH:26]1[CH2:30][CH2:29][CH2:28][C:27]1=O)=O)C>>[CH:1]1([C:7]2[CH:20]=[CH:19][C:10]([O:11][CH2:12][CH:13]3[O:17][C:16]4[N:15]([C:27]5[CH2:28][CH2:29][CH2:30][C:26]=5[C:24](=[O:23])[N:18]=4)[CH2:14]3)=[CH:9][CH:8]=2)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1참가 물질
3
실험 절차
The title compound was prepared from (S)-5-(4-cyclohexyl-phenoxymethyl)-4,5-dihydro-oxazol-2-ylamine and 2-oxo-cyclopentanecarboxylic acid ethyl ester in accordance with the procedures of O.-S. Adetchessi, et. al., Tetrahedron, 61, (2005), 4453-4460. C22H26N2O3 (366.19), LCMS (ESI): 367.16 (M++H).
출처 및 근거
- ORD 기록
- ord-8d297a2b37304c82b6279c2c360b9cd4
- 출처 데이터셋
- uspto-grants-2012_06